Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRKCA | P17252 | 4/20 | 0.49 |
| ▸ | DAGLA | Q9Y4D2 | 1/20 | 0.49 |
| ▸ | PRKD3 | O94806 | 1/20 | 0.45 |
| ▸ | PRKCG | P05129 | 1/20 | 0.45 |
| ▸ | PRKCB | P05771 | 1/20 | 0.45 |
| ▸ | PRKCH | P24723 | 1/20 | 0.45 |
| ▸ | PRKCE | Q02156 | 1/20 | 0.45 |
| ▸ | PRKCQ | Q04759 | 1/20 | 0.45 |
| ▸ | PRKCD | Q05655 | 1/20 | 0.45 |
| ▸ | PRKD1 | Q15139 | 1/20 | 0.45 |
| ▸ | LYPLA1 | O75608 | 3/20 | 0.43 |
| ▸ | LYPLA2 | O95372 | 3/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.42 |
| ▸ | PLA2G6 | O60733 | 2/20 | 0.41 |
| ▸ | PLA2G4A | P47712 | 1/20 | 0.41 |
| ▸ | ABHD16A | O95870 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19532095 | 0.98 | PRKCA (0.51) | PRKCADAGLAPRKD3PRKCGPRKCB | |
| SCHEMBL19532096 | 0.98 | PRKCA (0.51) | PRKCADAGLAPRKD3PRKCGPRKCB | |
| SCHEMBL19532103 | 0.98 | PRKCA (0.51) | PRKCADAGLAPRKD3PRKCGPRKCB | |
| SCHEMBL19532097 | 0.98 | PRKCA (0.51) | PRKCADAGLAPRKD3PRKCGPRKCB | |
| SCHEMBL576530 | 0.85 | — | — | |
| SCHEMBL16432856 | 0.83 | PRKCA (0.50) | PRKCADAGLAPRKD3PRKCGPRKCB | |
| SCHEMBL29512223 | 0.83 | PRKCA (0.50) | PRKCADAGLAPRKD3PRKCGPRKCB | |
| SCHEMBL16431984 | 0.83 | PRKCA (0.50) | PRKCADAGLAPRKD3PRKCGPRKCB | |
| SCHEMBL17867235 | 0.79 | PRKCA (0.42) | PRKCADAGLAPRKD3PRKCGPRKCB | |
| SCHEMBL21679663 | 0.78 | DAGLA (0.69) | PRKCADAGLAPRKD3PRKCGPRKCB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11814360-B2 | Isocyanates, derivatives, and processes for producing the same | NOVOMER, INC. (US) | 2023-11-14 | — | — | US | disclosed |
| US-11814498-B2 | Polylactone foams and methods of making the same | NOVOMER, INC. (US) | 2023-11-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11814360-B2 | Isocyanates, derivatives, and processes for producing the same | IDH1, IDH2, IDH3A | PRKCA 965/4885DAGLA 1546/4885PRKD3 2885/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.